WHO Posts Q&A to Clarify Guidelines on Biosimilars
The World Health Organization (WHO) invited comments on a draft question-and-answer document that aims to clarify its 2009 guidelines on the evaluation of biosimilars.
Source: Drug Industry Daily
The World Health Organization (WHO) invited comments on a draft question-and-answer document that aims to clarify its 2009 guidelines on the evaluation of biosimilars.
Source: Drug Industry Daily